Does APALUTAMIDE Cause Prostatic specific antigen increased? 251 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 251 reports of Prostatic specific antigen increased have been filed in association with APALUTAMIDE (ERLEADA). This represents 2.6% of all adverse event reports for APALUTAMIDE.
251
Reports of Prostatic specific antigen increased with APALUTAMIDE
2.6%
of all APALUTAMIDE reports
11
Deaths
37
Hospitalizations
How Dangerous Is Prostatic specific antigen increased From APALUTAMIDE?
Of the 251 reports, 11 (4.4%) resulted in death, 37 (14.7%) required hospitalization, and 4 (1.6%) were considered life-threatening.
Is Prostatic specific antigen increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APALUTAMIDE. However, 251 reports have been filed with the FAERS database.
What Other Side Effects Does APALUTAMIDE Cause?
Rash (1,117)
Death (1,008)
Fatigue (824)
Hot flush (532)
Product dose omission issue (384)
Diarrhoea (317)
Asthenia (303)
Dizziness (294)
Fall (268)
Off label use (257)
What Other Drugs Cause Prostatic specific antigen increased?
ENZALUTAMIDE (3,731)
LEUPROLIDE (2,432)
ABIRATERONE (1,581)
RADIUM RA-223 DICHLORIDE (449)
RELUGOLIX (335)
BICALUTAMIDE (322)
DOCETAXEL (282)
DENOSUMAB (220)
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (212)
OLAPARIB (176)
Which APALUTAMIDE Alternatives Have Lower Prostatic specific antigen increased Risk?
APALUTAMIDE vs APATINIB
APALUTAMIDE vs APIDRA
APALUTAMIDE vs APIDRA SOLOSTAR
APALUTAMIDE vs APIXABAN
APALUTAMIDE vs APLISOL DIAGNOSTIC ANTIGEN